Literature DB >> 20305012

Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.

Hoonmo L Koo1, Nadim J Ajami, Zhi-Dong Jiang, Frederick H Neill, Robert L Atmar, Charles D Ericsson, Pablo C Okhuysen, David N Taylor, A Louis Bourgeois, Robert Steffen, Herbert L DuPont.   

Abstract

Noroviruses (NoVs) are increasingly being recognized as an important enteric pathogen of gastroenteritis worldwide. The prevalence of NoVs as a cause of diarrhea acquired by travelers in developing countries is not well known. We examined the prevalence and importance of NoV infection in three international traveler cohorts with diarrhea acquired in three developing regions of the world, Mexico, Guatemala, and India. We also characterized the demographics and symptoms associated with NoV diarrhea in these travelers. Stool samples from 571 international travelers with diarrhea were evaluated for traditional enteropathogens. NoVs were identified using reverse transcription-PCR and probe hybridization. NoVs were identified in 10.2% of cases of travelers' diarrhea and, overall, was the second most common pathogen, following diarrheagenic Escherichia coli. The detection of NoV diarrhea significantly varied over the three study time periods in Guadalajara, Mexico, ranging from 3 of 98 (3.0%) diarrheal stools to 12 of 100 (12.0%) fecal specimens (P=0.03). The frequency of NoV diarrhea was also dependent upon the geographic region, with 17 of 100 (17.0%) travelers to Guatemala, 23 of 194 (11.9%) travelers to India, and 3 of 79 (3.8%) travelers to Mexico testing positive for NoVs from 2002 to 2003 (P=0.02). NoVs are important pathogens of travelers' diarrhea in multiple regions of the world. Significant variation in the prevalence of NoV diarrhea and in the predominant genogroup infecting travelers was demonstrated, dependent upon the specific geographic location and over time.

Entities:  

Mesh:

Year:  2010        PMID: 20305012      PMCID: PMC2863947          DOI: 10.1128/JCM.02072-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Detection of 'Norwalk-like viruses' in Vellore, southern India.

Authors:  G Kang; A D Hale; A F Richards; M V Jesudason; M K Estes; D W Brown
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.184

2.  Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay).

Authors:  Zhi-Dong Jiang; Brett Lowe; M P Verenkar; David Ashley; Robert Steffen; Nadia Tornieporth; Frank von Sonnenburg; Peter Waiyaki; Herbert L DuPont
Journal:  J Infect Dis       Date:  2002-01-22       Impact factor: 5.226

3.  Risk and aetiology of diarrhoea at various tourist destinations.

Authors:  F von Sonnenburg; N Tornieporth; P Waiyaki; B Lowe; L F Peruski; H L DuPont; J J Mathewson; R Steffen
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

4.  Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala.

Authors:  Ellen B Steinberg; Carlos E Mendoza; Roger Glass; Byron Arana; M Beatriz Lopez; Maricruz Mejia; Benjamin D Gold; Jeffrey W Priest; William Bibb; Stephan S Monroe; Caryn Bern; Beth P Bell; Robert M Hoekstra; Robert Klein; Eric D Mintz; Stephen Luby
Journal:  Am J Trop Med Hyg       Date:  2004-01       Impact factor: 2.345

5.  Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers.

Authors:  Carol O Tacket; Marcelo B Sztein; Genevieve A Losonsky; Steven S Wasserman; Mary K Estes
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

6.  Multistate outbreak of Norwalk-like virus gastroenteritis associated with a common caterer.

Authors:  A D Anderson; V D Garrett; J Sobel; S S Monroe; R L Fankhauser; K J Schwab; J S Bresee; P S Mead; C Higgins; J Campana; R I Glass
Journal:  Am J Epidemiol       Date:  2001-12-01       Impact factor: 4.897

7.  Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.

Authors:  H L DuPont; Z D Jiang; C D Ericsson; J A Adachi; J J Mathewson; M W DuPont; E Palazzini; L M Riopel; D Ashley; F Martinez-Sandoval
Journal:  Clin Infect Dis       Date:  2001-10-23       Impact factor: 9.079

8.  Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world.

Authors:  J A Adachi; Z D Jiang; J J Mathewson; M P Verenkar; S Thompson; F Martinez-Sandoval; R Steffen; C D Ericsson; H L DuPont
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

9.  Human caliciviruses detected in Mexican children admitted to hospital during 1998-2000, with severe acute gastroenteritis not due to other enteropathogens.

Authors:  Ana Lorena Gutiérrez-Escolano; F Raúl Velázquez; Jaime Escobar-Herrera; Catalina López Saucedo; Javier Torres; Teresa Estrada-García
Journal:  J Med Virol       Date:  2010-04       Impact factor: 2.327

10.  A summertime peak of "winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002.

Authors:  Ben A Lopman; Mark Reacher; Chris Gallimore; Goutam K Adak; Jim J Gray; David W G Brown
Journal:  BMC Public Health       Date:  2003-03-24       Impact factor: 3.295

View more
  18 in total

1.  Use and Interpretation of Enteropathogen Multiplex Nucleic Acid Amplification Tests in Patients With Suspected Infectious Diarrhea.

Authors:  Harika Yalamanchili; Dima Dandachi; Pablo C Okhuysen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-11

2.  Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.

Authors:  Sue E Crawford; Nadim Ajami; Tracy Dewese Parker; Noritoshi Kitamoto; Katsuro Natori; Naokazu Takeda; Tomoyuki Tanaka; Baijun Kou; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

Review 3.  Noroviruses: The leading cause of gastroenteritis worldwide.

Authors:  Hoonmo L Koo; Nadim Ajami; Robert L Atmar; Herbert L DuPont
Journal:  Discov Med       Date:  2010-07       Impact factor: 2.970

4.  Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients.

Authors:  X Ye; J N Van; F M Munoz; P A Revell; C A Kozinetz; R A Krance; R L Atmar; M K Estes; H L Koo
Journal:  Am J Transplant       Date:  2015-03-18       Impact factor: 8.086

5.  Characterization of norovirus-associated traveler's diarrhea.

Authors:  N Ajami; H Koo; C Darkoh; R L Atmar; P C Okhuysen; Z-D Jiang; J Flores; H L Dupont
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

6.  Seroepidemiology of norovirus-associated travelers' diarrhea.

Authors:  Nadim J Ajami; Owen V Kavanagh; Sasirekha Ramani; Sue E Crawford; Robert L Atmar; Zhi-Dong Jiang; Pablo C Okhuysen; Mary K Estes; Herbert L DuPont
Journal:  J Travel Med       Date:  2014 Jan-Feb       Impact factor: 8.490

Review 7.  Advances in the treatment of travelers' diarrhea.

Authors:  Mercedes Paredes-Paredes; Jose Flores-Figueroa; Herbert L Dupont
Journal:  Curr Gastroenterol Rep       Date:  2011-10

8.  New Developments in Traveler's Diarrhea.

Authors:  Javier de la Cabada Bauche; Herbert L Dupont
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

9.  Prevalence and genetic diversity of norovirus among patients with acute diarrhea in Guatemala.

Authors:  Alejandra Estévez; Wences Arvelo; Aron J Hall; María R López; Beatriz López; Lissette Reyes; Juan Carlos Moir; Nicole Gregoricus; Jan Vinjé; Umesh D Parashar; Kim A Lindblade
Journal:  J Med Virol       Date:  2013-04-17       Impact factor: 2.327

Review 10.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.